BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update

Go back to BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
(NASDAQ: BBIO) Delayed: 68.92 --0 (-0%)
Previous Close $68.92    52 Week High
Open $68.92    52 Week Low
Day High $68.92    P/E N/A 
Day Low $68.92    EPS
Volume 117